These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 12956723)

  • 21. Repeated acetyl-l-carnitine administration increases phospho-Thr34 DARPP-32 levels and antagonizes cocaine-induced increase in Cdk5 and phospho-Thr75 DARPP-32 levels in rat striatum.
    Scheggi S; Rauggi R; Nanni G; Tagliamonte A; Gambarana C
    Eur J Neurosci; 2004 Mar; 19(6):1609-20. PubMed ID: 15066157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine and cyclic AMP-regulated phosphoprotein-32 phosphorylation pattern in cocaine and morphine-sensitized rats.
    Scheggi S; Rauggi R; Gambarana C; Tagliamonte A; De Montis MG
    J Neurochem; 2004 Aug; 90(4):792-9. PubMed ID: 15287884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bidirectional regulation of DARPP-32 phosphorylation by dopamine.
    Nishi A; Snyder GL; Greengard P
    J Neurosci; 1997 Nov; 17(21):8147-55. PubMed ID: 9334390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors.
    Svenningsson P; Lindskog M; Ledent C; Parmentier M; Greengard P; Fredholm BB; Fisone G
    Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1856-60. PubMed ID: 10677546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. mGlu5R promotes glutamate AMPA receptor phosphorylation via activation of PKA/DARPP-32 signaling in striatopallidal medium spiny neurons.
    Dell'anno MT; Pallottino S; Fisone G
    Neuropharmacology; 2013 Mar; 66():179-86. PubMed ID: 22507666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons.
    Bibb JA; Snyder GL; Nishi A; Yan Z; Meijer L; Fienberg AA; Tsai LH; Kwon YT; Girault JA; Czernik AJ; Huganir RL; Hemmings HC; Nairn AC; Greengard P
    Nature; 1999 Dec; 402(6762):669-71. PubMed ID: 10604473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of DARPP-32 phosphorylation by Delta9-tetrahydrocannabinol.
    Borgkvist A; Marcellino D; Fuxe K; Greengard P; Fisone G
    Neuropharmacology; 2008 Jan; 54(1):31-5. PubMed ID: 17686497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antagonistic effects of dopaminergic signaling and ethanol on protein kinase A-mediated phosphorylation of DARPP-32 and the NR1 subunit of the NMDA receptor.
    Edwards S; Simmons DL; Galindo DG; Doherty JM; Scott AM; Hughes PD; Wilcox RE
    Alcohol Clin Exp Res; 2002 Feb; 26(2):173-80. PubMed ID: 11964556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DARPP-32 and modulation of cAMP signaling: involvement in motor control and levodopa-induced dyskinesia.
    Håkansson K; Lindskog M; Pozzi L; Usiello A; Fisone G
    Parkinsonism Relat Disord; 2004 Jul; 10(5):281-6. PubMed ID: 15196506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct and indirect actions of dopamine on the membrane potential in medium spiny neurons of the mouse neostriatum.
    Yasumoto S; Tanaka E; Hattori G; Maeda H; Higashi H
    J Neurophysiol; 2002 Mar; 87(3):1234-43. PubMed ID: 11877497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ARPP-16 Is a Striatal-Enriched Inhibitor of Protein Phosphatase 2A Regulated by Microtubule-Associated Serine/Threonine Kinase 3 (Mast 3 Kinase).
    Andrade EC; Musante V; Horiuchi A; Matsuzaki H; Brody AH; Wu T; Greengard P; Taylor JR; Nairn AC
    J Neurosci; 2017 Mar; 37(10):2709-2722. PubMed ID: 28167675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glutamate Counteracts Dopamine/PKA Signaling via Dephosphorylation of DARPP-32 Ser-97 and Alteration of Its Cytonuclear Distribution.
    Nishi A; Matamales M; Musante V; Valjent E; Kuroiwa M; Kitahara Y; Rebholz H; Greengard P; Girault JA; Nairn AC
    J Biol Chem; 2017 Jan; 292(4):1462-1476. PubMed ID: 27998980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DARPP-32: an integrator of neurotransmission.
    Svenningsson P; Nishi A; Fisone G; Girault JA; Nairn AC; Greengard P
    Annu Rev Pharmacol Toxicol; 2004; 44():269-96. PubMed ID: 14744247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DARPP-32 mediates serotonergic neurotransmission in the forebrain.
    Svenningsson P; Tzavara ET; Liu F; Fienberg AA; Nomikos GG; Greengard P
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):3188-93. PubMed ID: 11880652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amplification of dopaminergic signaling by a positive feedback loop.
    Nishi A; Bibb JA; Snyder GL; Higashi H; Nairn AC; Greengard P
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12840-5. PubMed ID: 11050161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of the cAMP/PKA/DARPP-32 signaling pathway is required for morphine psychomotor stimulation but not for morphine reward.
    Borgkvist A; Usiello A; Greengard P; Fisone G
    Neuropsychopharmacology; 2007 Sep; 32(9):1995-2003. PubMed ID: 17251906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A dopamine/D1 receptor/protein kinase A/dopamine- and cAMP-regulated phosphoprotein (Mr 32 kDa)/protein phosphatase-1 pathway regulates dephosphorylation of the NMDA receptor.
    Snyder GL; Fienberg AA; Huganir RL; Greengard P
    J Neurosci; 1998 Dec; 18(24):10297-303. PubMed ID: 9852567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of phosphorylation of the GluR1 AMPA receptor in the neostriatum by dopamine and psychostimulants in vivo.
    Snyder GL; Allen PB; Fienberg AA; Valle CG; Huganir RL; Nairn AC; Greengard P
    J Neurosci; 2000 Jun; 20(12):4480-8. PubMed ID: 10844017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of cyclin-dependent kinase 5 and casein kinase 1 by metabotropic glutamate receptors.
    Liu F; Ma XH; Ule J; Bibb JA; Nishi A; DeMaggio AJ; Yan Z; Nairn AC; Greengard P
    Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11062-8. PubMed ID: 11572969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of DARPP-32 in the actions of drugs of abuse.
    Nairn AC; Svenningsson P; Nishi A; Fisone G; Girault JA; Greengard P
    Neuropharmacology; 2004; 47 Suppl 1():14-23. PubMed ID: 15464122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.